News

Dec 31,2022

ONCOC4 ANNOUNCES FIRST PATIENT DOSED IN PRESERVE-004, A PHASE 2 CLINICAL TRIAL OF ONC-392 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER

read more >>

Dec 15,2022

Avirmax CMC Inc. Successfully Manufactured and Delivered to a Client the First Lot of rAAV Drug Product for a Monkey Toxicology Study

read more >>

Nov 30,2022

KBP Presents Results of the Hepatic Impairment Study and Drug-Drug Interaction Study of Ocedurenone (KBP-5074) at ASN Kidney Week 2022

read more >>

Nov 29,2022

Aravive Announces Fast Track Designation of Batiraxcept for Treatment of ccRCC

read more >>

Nov 17,2022

Apexigen Announces Positive Interim Results from Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Doxorubicin in Patients with Liposarcoma

read more >>

Nov 11,2022

Subtle Medical Joins Imaging AI in Practice Demonstration at RSNA 2022

read more >>

Nov 10,2022

Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M

read more >>

Nov 08,2022

Profusa, Inc., a Digital Health Company, Pioneering the Next Generation of Personalized Medicine, to Become a Publicly Traded Company Via Merger with NorthView Acquisition Corp

read more >>

Next page